518978-03-5 Usage
General Description
2-(benzyloxy)-5-cyanobenzoic acid is a chemical compound with the molecular formula C15H11NO4. It consists of a benzene ring with a benzyloxy group and a cyanobenzoic acid group attached to it. 2-(benzyloxy)-5-cyanobenzoic acid is commonly used in organic chemistry as a building block for the synthesis of other chemicals and pharmaceuticals. It has a wide range of applications, including as an intermediate in the production of dyes, pigments, and pharmaceuticals. 2-(benzyloxy)-5-cyanobenzoic acid is known for its high purity and stability, making it an important reagent in chemical research and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 518978-03-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,1,8,9,7 and 8 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 518978-03:
(8*5)+(7*1)+(6*8)+(5*9)+(4*7)+(3*8)+(2*0)+(1*3)=195
195 % 10 = 5
So 518978-03-5 is a valid CAS Registry Number.
518978-03-5Relevant articles and documents
METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY
-
, (2021/10/02)
Disclosed are methods of treating creatine transporter deficiency, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound that increases transport of a substrate by a mutant or wild-type creatine transporter. Also disclosed are methods of increasing transport of guanidinoacetic acid or a salt thereof across the blood-brain barrier of a mammal, and methods of decreasing accumulation or the concentration of guanidinoacetic acid or a salt thereof in a mammalian cell.
NOVEL COMPOUNDS
-
, (2011/04/25)
The present invention discloses novel compounds inhibiting LRRK2 kinase activity, the preparation processes thereof, the compositions containing them, as well as the use in treating diseases characterized by LRRK2 kinase activity, particularly Parkinson's disease and Alzheimer's disease.
